Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avinger Inc
(NQ:
AVGR
)
1.150
+0.080 (+7.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Avinger Inc
< Previous
1
2
3
Next >
Avinger Reports Second Quarter 2024 Results
August 08, 2024
Via
ACCESSWIRE
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
August 05, 2024
Via
ACCESSWIRE
Avinger to Announce Second Quarter 2024 Results on August 8, 2024
July 29, 2024
Via
ACCESSWIRE
Avinger Announces Closing of up to $24 Million Public Offering
June 17, 2024
Via
ACCESSWIRE
Avinger Announces Pricing of up to $24 Million Public Offering
June 14, 2024
Via
ACCESSWIRE
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
June 05, 2024
Via
ACCESSWIRE
Avinger Reports First Quarter 2024 Results
May 15, 2024
Via
ACCESSWIRE
Avinger Reports Fourth Quarter and Full Year 2023 Results
March 20, 2024
Via
ACCESSWIRE
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
March 06, 2024
Via
ACCESSWIRE
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
May 16, 2024
Via
ACCESSWIRE
Avinger to Announce First Quarter 2024 Results on May 15, 2024
May 07, 2024
Via
ACCESSWIRE
Avinger to Announce Full Year 2023 Results on March 20, 2024
March 12, 2024
Via
ACCESSWIRE
Avinger Reports Third Quarter 2023 Results
October 26, 2023
Via
ACCESSWIRE
Avinger to Announce Third Quarter 2023 Results on October 26
October 19, 2023
Via
ACCESSWIRE
Avinger Inc. (NASDAQ: AVGR) Leading the Way in Monday Trading Based on Percentage Gain
October 16, 2023
Via
Investor Brand Network
Avinger Raises $5.3 Million via At-The-Market Facility
September 27, 2023
Via
ACCESSWIRE
Avinger Inc. (NASDAQ: AVGR) Near the Top of Equities by Percentage Gain on 9/19
September 19, 2023
Via
Investor Brand Network
Avinger Inc. (NASDAQ: AVGR) Near Top of Volume Charts in Monday Trading
September 18, 2023
Via
Investor Brand Network
Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device
September 18, 2023
Via
ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023
August 24, 2023
Via
ACCESSWIRE
Avinger Announces Conversion of 12% of CRG Term Debt into Equity
August 04, 2023
Via
ACCESSWIRE
Avinger to Announce Second Quarter 2023 Results on July 27
July 20, 2023
Via
ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at LINC 2023
June 20, 2023
Via
ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
June 09, 2023
Via
ACCESSWIRE
Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System
June 07, 2023
Via
ACCESSWIRE
Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device
June 05, 2023
Via
ACCESSWIRE
Avinger Reports First Quarter 2023 Results
May 10, 2023
Via
ACCESSWIRE
Avinger to Announce First Quarter 2023 Results on May 10
May 02, 2023
Via
ACCESSWIRE
Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium
April 28, 2023
Via
ACCESSWIRE
Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
April 26, 2023
Via
ACCESSWIRE
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.